Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine
Science Advances · 18.07.2025 · 11 (29)
DOI: 10.1126/sciadv.adt1318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 18.07.2025. Verfasst von Peng Lou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery and NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Regenerative Medicine, Mitochondria, Organelle Biogenesis. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Mitochondrial damage is a critical pathological factor in various forms of tissue injury, and specific therapies with high biosafety are desirable. Inspired by the natural role of extracellular vesicles (EVs) in regulating mitochondrial metabolism, we report that healthy tissue-derived mitochondria-rich EVs (Ti-mitoEVs) can boost mitochondrial biogenesis for regenerative medicine. Ti-mitoEVs that contain abundant functional mitochondria can be highly efficiently isolated from muscles via an optimized method. In vitro, Ti-mitoEV treatment increased mitochondrial biogenesis and reduced mitochondrial damage in recipient cells, and these effects occurred at least partly via mitochondrial genome transfer. In vivo, Ti-mitoEV treatment attenuated diverse types of tissue injury (e.g., muscle and kidney) by rescuing mitochondrial injury and its associated inflammation. As natural nanovesicles, the therapeutic potency of mitoEVs can be further improved by integrating them with other engineering methods. This study highlights the promising role of Ti-mitoEVs in boosting mitochondrial biogenesis, positioning them as potential therapies for treating various types of tissue injury characterized by mitochondrial damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Surgery and NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, Chi…
- Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China.
- West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Peng Lou, Xiyue Zhou, Chengshi Wang, Yanrong Lu, Jingping Liu
Zitieren
APA
Lou, P., Zhou, X., Zhang, Y., Xie, Y., Wang, Y., Wang, C., Liu, S., Wan, M., Lu, Y., & Liu, J. (2025). Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine. Science Advances, 11(29). https://doi.org/10.1126/sciadv.adt1318
Vancouver
Lou P, Zhou X, Zhang Y, Xie Y, Wang Y, Wang C, et al. Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine. Science Advances. 2025;11(29). doi:10.1126/sciadv.adt1318
BibTeX
@article{Lou2025,
author = {Lou, Peng and Zhou, Xiyue and Zhang, Yimeng and Xie, Yijing and Wang, Yizhuo and Wang, Chengshi and Liu, Shuyun and Wan, Meihua and Lu, Yanrong and Liu, Jingping},
title = {Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {29},
doi = {10.1126/sciadv.adt1318}
}
EUVIMED